Q1 2024 Holdings
Filed 2024-05-15 | 208 holdings | $6.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $27.0M | 1,220,085 | 0.4% |
| Silk RD MED Inc | COM | 82710M100 | $27.8M | 1,518,230 | 0.4% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $27.9M | 473,915 | 0.4% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $28.1M | 321,787 | 0.4% |
| Centene Corp del(CNC) | COM | 15135B101 | $28.5M | 363,100 | 0.4% |
| The Cigna Group(CI) | COM | 125523100 | $28.9M | 79,645 | 0.4% |
| Globus MED Inc(GMED) | CL A | 379577208 | $31.1M | 579,898 | 0.5% |
| Cencora Inc(COR) | COM | 03073E105 | $32.0M | 131,504 | 0.5% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $32.6M | 251,521 | 0.5% |
| Shockwave MED Inc(SWAVUSD) | COM | 82489T104 | $34.4M | 105,786 | 0.5% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $35.5M | 4,839,779 | 0.5% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $37.2M | 282,217 | 0.6% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $38.5M | 2,165,203 | 0.6% |
| Veeva SYS Inc(VEEV) | CL A COM | 922475108 | $39.0M | 168,247 | 0.6% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $39.4M | 1,193,121 | 0.6% |
| Cooper COS Inc(COO) | COM | 216648501 | $40.3M | 397,373 | 0.6% |
| Penumbra Inc(PEN) | COM | 70975L107 | $40.4M | 181,158 | 0.6% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $41.0M | 310,851 | 0.6% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $41.0M | 99,883 | 0.6% |
| Caredx Inc(CDNA) | COM | 14167L103 | $41.7M | 3,934,006 | 0.6% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $42.3M | 619,950 | 0.6% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $43.2M | 8,517,839 | 0.7% |
| Procept Biorobotics Corp(PRCT) | COM | 74276L105 | $44.0M | 890,114 | 0.7% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $45.1M | 57,965 | 0.7% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $45.2M | 1,903,200 | 0.7% |
| GE Healthcare Technologies I(GEHC) | COMMON STOCK | 36266G107 | $46.6M | 512,230 | 0.7% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $46.8M | 217,694 | 0.7% |
| Humana Inc(HUM) | COM | 444859102 | $47.0M | 135,541 | 0.7% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $48.6M | 1,483,096 | 0.7% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $49.2M | 5,926,618 | 0.8% |
| Accolade Inc(ACCDEUR) | COM | 00437E102 | $50.4M | 4,804,514 | 0.8% |
| Insulet Corp(PODD) | COM | 45784P101 | $50.4M | 293,828 | 0.8% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $50.4M | 93,358 | 0.8% |
| Align Technology Inc(ALGN) | COM | 016255101 | $50.8M | 154,909 | 0.8% |
| Elevance Health Inc(ELV) | COM | 036752103 | $51.1M | 98,612 | 0.8% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $53.3M | 159,703 | 0.8% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $54.2M | 156,618 | 0.8% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $54.7M | 685,476 | 0.8% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $58.1M | 2,141,843 | 0.9% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $62.2M | 229,697 | 0.9% |
| Option Care Health Inc(OPCH) | COM NEW | 68404L201 | $62.6M | 1,867,263 | 1.0% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $62.9M | 1,150,000 | 1.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $63.2M | 972,254 | 1.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $67.0M | 7,889,583 | 1.0% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $71.9M | 2,031,888 | 1.1% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $73.6M | 148,719 | 1.1% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $78.6M | 1,138,526 | 1.2% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $83.7M | 4,465,544 | 1.3% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $87.8M | 1,007,000 | 1.3% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $98.7M | 2,390,800 | 1.5% |